Graduate School of Defense Management, Naval Postgraduate School (Y.-C.S.).
National Bureau of Economic Research (Y.-C.S.).
Circ Cardiovasc Qual Outcomes. 2021 Mar;14(3):e007195. doi: 10.1161/CIRCOUTCOMES.120.007195. Epub 2021 Mar 1.
Regionalization of ST-segment elevation myocardial infarction (STEMI) systems of care has been championed over the past decade. Although timely access to percutaneous coronary intervention (PCI) has been shown to improve outcomes, no studies have determined how regionalization has affected the care and outcomes of patients. We sought to determine if STEMI regionalization is associated with changes in access, treatment, and outcomes.
Using a difference-in-differences approach, we analyzed a statewide, administrative database of 139 494 patients with STEMI in California from 2006 to 2015 using regionalization data based on a survey of all local Emergency Medical Services agencies in the state.
For patients with STEMI, the base rate of admission to a hospital with PCI capability was 72.7%, and regionalization was associated with an increase of 5.34 percentage points (95% CI, 1.58-9.10), representing a 7.1% increase. Regionalization was also associated with a statistically significant increase of 3.54 (95% CI, 0.61-6.48) percentage points in the probability of same-day PCI, representing an increase of 7.1% from the 49.7% base rate and a 4.6% relative increase (2.97 percentage points [95% CI, 0.1-5.85]) in the probability of receiving PCI at any time during the hospitalization. There was a 1.84 percentage point decrease (95% CI, -3.31 to -0.37) in the probability of receiving fibrinolytics. For 7-day mortality, regionalization was associated with a 0.53 (95% CI, -1 to -0.06) percentage point greater reduction (representing 5.8% off the base rate of 9.1%) and a 1.75 percentage point decrease in the likelihood of all-cause 30-day readmission (95% CI, -3.39 to -0.11; representing 6.4% off the base rate of 27.4%). No differences were found in longer-term mortality.
Among patients with STEMI in California from 2006 to 2015, STEMI regionalization was associated with increased access to a PCI-capable hospital, greater use of PCI, lower 7-day mortality, and lower 30-day readmissions.
在过去的十年中,ST 段抬高型心肌梗死(STEMI)的区域化医疗系统一直备受推崇。虽然及时进行经皮冠状动脉介入治疗(PCI)已被证明可以改善预后,但尚无研究确定区域化如何影响患者的治疗和预后。我们试图确定 STEMI 区域化是否与患者获得治疗的途径、治疗方法和结果的变化有关。
我们使用差异中的差异方法,分析了 2006 年至 2015 年加利福尼亚州的 139494 例 STEMI 患者的全州行政数据库,该数据库基于对全州所有当地紧急医疗服务机构的调查的区域化数据。
对于 STEMI 患者,入组 PCI 能力医院的基础率为 72.7%,区域化与 5.34 个百分点的增加相关(95%CI,1.58-9.10),代表增加 7.1%。区域化还与当天进行 PCI 的概率增加 3.54 个百分点(95%CI,0.61-6.48)具有统计学意义相关,代表从 49.7%的基础率增加了 7.1%,相对增加 4.6%(2.97 个百分点[95%CI,0.1-5.85]),在住院期间任何时间接受 PCI 的概率。接受纤溶酶的概率降低了 1.84 个百分点(95%CI,-3.31 至-0.37)。对于 7 天死亡率,区域化与降低 0.53 个百分点(95%CI,-1 至-0.06)相关(代表从 9.1%的基础率降低 5.8%),30 天全因再入院的可能性降低 1.75 个百分点(95%CI,-3.39 至-0.11;代表从 27.4%的基础率降低 6.4%)。在长期死亡率方面没有发现差异。
在 2006 年至 2015 年期间加利福尼亚州的 STEMI 患者中,STEMI 区域化与能够进行 PCI 的医院的就诊机会增加、PCI 的应用增加、7 天死亡率降低和 30 天再入院率降低相关。